Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Lestaurtinib | 0.3 | uM | 1 | MCP3 | 28.0 | 67 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 1 | MCP3 | 23.0 | 57 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 1 | MCP3 | 25.0 | 83 | ||||
RA2159 | IKK16 | 2.0 | uM | 1 | MCP3 | 24.0 | 76 | ||||
RA2159 | JNK-IN-8 | 3.0 | uM | 1 | MCP3 | 30.0 | 45 | ||||
N2586 | 1 | MCP3 | 57.0 | 54 | |||||||
N2586 | PD184352 | 0.1 | uM | 1 | MCP3 | 57.0 | 46 | ||||
N2586 | Lestaurtinib | 0.3 | uM | 1 | MCP3 | 49.0 | 55 | ||||
N2586 | Ruxolitinib | 0.3 | uM | 1 | MCP3 | 60.0 | 63 | ||||
N2586 | Tofacitinib | 0.3 | uM | 1 | MCP3 | 63.0 | 73 | ||||
N2586 | IKK16 | 2.0 | uM | 1 | MCP3 | 53.0 | 47 | ||||
N2586 | JNK-IN-8 | 3.0 | uM | 1 | MCP3 | 41.5 | 46 | ||||
RA2159 | EGF | 100 | ng/mL | 1 | MCP3 | 28.5 | 60 | ||||
RA2159 | PD184352 | 0.1 | uM | EGF | 100 | ng/mL | 1 | MCP3 | 24.0 | 68 | |
RA2159 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | MCP3 | 25.0 | 82 | |
RA2159 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | MCP3 | 26.0 | 62 | |
RA2159 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | MCP3 | 33.0 | 59 | |
RA2159 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 1 | MCP3 | 28.5 | 64 | |
RA2159 | JNK-IN-11 | 0.3 | uM | 1 | MCP3 | 29.0 | 49 | ||||
N2586 | EGF | 100 | ng/mL | 1 | MCP3 | 75.5 | 62 | ||||
N2586 | PD184352 | 0.1 | uM | EGF | 100 | ng/mL | 1 | MCP3 | 65.0 | 73 | |
N2586 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | MCP3 | 48.0 | 56 | |
N2586 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | MCP3 | 69.0 | 77 | |
N2586 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | MCP3 | 78.0 | 54 | |
N2586 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 1 | MCP3 | 61.0 | 62 |